Viewing Study NCT01284868


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2026-01-01 @ 3:02 AM
Study NCT ID: NCT01284868
Status: COMPLETED
Last Update Posted: 2013-07-03
First Post: 2011-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module